Abstract 24
The traditional concept that heritability occurs exclusively from the transfer of germline-restricted 25 genetics is being challenged by the increasing accumulation of evidence confirming the existence of 26 experience-dependent transgenerational inheritance. Transgenerational inheritance is emerging as a 27 powerful mechanism for robustly transmitting phenotypic adaptations to offspring. However, questions 28 remain unanswered as to how this heritable information is passed from somatic cells. Previous studies 29 have implicated the critical involvement of RNA in heritable transgenerational effects and the high 30 degree of mobility and genomic impact of RNAs in all organisms is an attractive model for the efficient 31 transfer of genetic information. Here we show, for the first time, robust transport of RNA from the brain 32 of an adult male mouse to sperm, and subsequently to offspring. Our observation of heritable genetic 33 information originating from a somatic tissue may reveal a mechanism for how transgenerational effects 34 are transmitted to offspring. In order to test this hypothesis and trace genetic information from a somatic tissue to the germline in 56 male mice, and to circumvent the issue of pervasive gene expression in sperm (Soumillon, et al. 2013 ), 57 we introduced a 72bp RNA encompassing a pre-isoform of a human-specific microRNA (MIR) 941, pre-58 MIR941-1 (Hu, et al. 2012) , via an adeno-associated virus (AAV) gene delivery system (Supplementary 59 Figure 1 ), into one hemisphere of the mouse striatum using stereotactic injection. The AAV serotype 1/9 60 (AAV1/9) vector, a single-stranded DNA packaging virus, has been shown to infect both neurons and 61 astrocytes (Foust, et al. 2009; Hammond, et al. 2017 ). The AAV1 vector was designed to also produce a 62 single stranded DNA fragment of the rabbit β-globin gene which is used commercially for determining 63 viral titre. We used this gene fragment to determine presence of the virus. Despite the fact that the AAV1 64 virus can be retrogradely transported via axons to the contralateral region (Hutson, et al. 2016 ) and the 65 cerebellum (Xiao, et al. 2018) , this system allowed us to restrict viral infection to the target site, and to 66 discrete regions of the mouse brain while then specifically monitoring potential transport of virally-67 expressed pre-MIR941-1 outside of the brain using gene-specific PCR. 68
We initially sought to determine the specificity, reproducibility and detection limit using a locked nucleic 69 acid (LNA) quantitative PCR (qPCR) system. Our methodological approach required a minimum length 70 of the desired PCR product, hence the reason we targeted the 72bp pre-isoform transcript of MIR941-1 71 as opposed to the mature 24bp transcript. Henceforth, we will use the term 'MIR941' to describe the pre-72 MIR941-1 transcript. Using serial dilutions of positive control injection sites, qPCR reactions produced 73 single bands of both MIR941 and rabbit β-globin as detected on an agarose gel (Supplementary Figure  74 2). We found that we could detect MIR941 down to a 1:100 dilution (starting with 60ng RNA; 75
Supplementary Figure 2A ) while the AAV1 virus could be detected down to a ~1:15,000 dilution 76 (starting with 60ng DNA; Supplementary Figure 2B ). We could not detect either MIR941 or rabbit β-77 globin fragment in control or mock-treated animals (Supplementary Figure 3 injected mice after two weeks prompted us to investigate whether this transcript may be transmitted to 85 offspring. As a full cycle of spermatogenesis takes ~5 weeks in mice, we mated male mice, after 6-8 86 weeks post-injection, with wildtype female mice. This would serve to increase the probability that brain-87 derived MIR941 had sufficient time to enter the testis and complete spermatogenesis. Male mice were 88 sacrificed after 8 weeks and embryos were collected from wildtype female mice at 7.5 days post coitum 89 (d.p.c.). Here we again detected MIR941 in samples from the injection and contralateral sites, 90 cerebellum, lymph node and V/E (Figure 2 ; Supplementary Figures 6, 7) . Crucially, we additionally 91 detected MIR941 in 9 of the 18 embryos screened that originated from males treated with 92 AAV1/MIR941. Viral presence was restricted to brain samples (Figure 2 ; Supplementary Figure 6 ). 93
We postulated that although we could detect MIR941 in some of the embryos, extending the time after 94 injection and before mating may increase the detectability of MIR941 in embryos. Hence, we waited 95 until 14 weeks post-injection to begin mating treated males with wildtype females and sacrificed the 96 males at 16 weeks post-injection. Here we observed 17 out 60 embryos that were indeed positive for 97 MIR941 (Figure 3 ; Supplementary Figure 8 ). These animals also reflected our previous results where 98 MIR941 was detected in the injection and contralateral sites, cerebellum, lymph node and V/E but not in 99 whole blood and liver. Viral presence was again only observed in discrete brain regions ( Figure 3 ; 100
The persistent presence of MIR941 in the lymph node does suggest that the mode of transport may be in 102 both the lymphatic and circulatory systems considering their closely associated capillary transport of 103 nutrients and small vesicles. We reasoned that MIR941 would be required to be contained in a vesicle so 104 that degradation does not occur during transport, and vesicles are shared between the blood and the lymph 105 due to their smaller size. However, whole blood, as opposed to the lymph node which collects lymph 106 over a longer timeframe, may not be a suitable sample to detect what would be a very small amount of 107 MIR941 at any one point, as blood flows faster than lymph. Therefore, in order to investigate whether 108 MIR941 is present in the blood of the treated male mice we used a series of microcentrifuge and 109 ultracentrifuge spins to isolate the fraction of whole blood that contains vesicles. We were not successful 110 in detecting MIR941 in both the 2 or 8 week samples and only detected the presence of the miRNA in 111 one of the 16 week samples in the ultracentrifuge fraction that is presumed to contain the highest 112 concentration of vesicles ( Supplementary Figures 9A, B) . No presence of the virus was found in any of 113 these samples (Supplementary Figure 9C) . 114
Our data verify that RNAs are able to be physically transmitted from a somatic tissue, in this case the 115 brain, to the germline and to offspring in male mice. We are unable to confirm the exact prevalence 116 because our current detection limits may not capture all positive samples, since our experimental design 117 imposed a low level of viral infection so as not to flood the endogenous system. However, the 118 demonstration that a third of embryos contain the MIR941 transcript after 8 and 16 weeks post-injection 119 does suggest that this is a significant mechanism and sets the foundation for direct measurements of the 120 extent of somatic inheritance in different species. All animal procedures were approved by the QIMRB Animal Ethics committee, ethics #A1612-622M. 173 C57BL/6J (Jax code 000664) were obtained from Animal Resource Centre (Canning Vale). 174
Brain injections 175
Male C57BL/6J aged 6-7 weeks were administered analgesia (Meloxicam 5mg/kg) 30 minutes prior to 176 surgery. Animals were anaesthetized using inhaled isoflurane (2%) and once anaesthetized were 177 transferred onto the stereotactic device with nose cone attachment for continuous isoflurane 178 administration. Once the mouse was adequately anaesthetized by evidence of pedal withdrawal reflex, 179 the animal's head was clipped, disinfected using an alcohol swab, the skin was incised and a 2mm drill 180 hole was made and a solution (1-2ul) containing AAV vector was injected (Hamilton syringe) into the 181 lateral portion of the striatum. Injections were made over a period of 3 minutes to ensure optimal 182 parenchymal compliance. The micro-injector needle was retracted, the bur hole was plugged with bone 183 wax, a 'splash block' of Bupivacaine (5mg/kg) was applied to the skull/periosteum and the skin closed 184 with tissue adhesive (VetBond). Animals were returned to their cages, given free access to food and 185 water and monitored daily for any signs of neurological dysfunction. On the day following surgery the 186 animals were administered another dose of analgesia (Meloxicam 5mg/kg). 187
Timed matings 188
Wildtype C57BL/6J females aged 6-8 weeks were set up overnight with a male. The following morning 189 presence of a vaginal plug assumed that mating/fertilization occurred. We determine that embryos at 190 this stage are aged 0.5 days post coitum (d.p.c). 191
Collection of Embryos 192
Post implantation embryos at 7.5 d.p.c were collected from euthanized pregnant females. The uterine 193 horn was dissected out and placed in ice cold PBS. The embryos were separated by cutting between 194 implantation sites along the uterine horn. The surrounding muscle layer is peeled back to expose the 195 decidua. Individual embryos still encased in decidua tissue were flash frozen on dry ice and stored at -196 80°C until homogenization for nucleic acid extraction. 197
Dissection for tissue collection 198
For tissue collection, animals were anaesthetized and then cardiac puncture was performed. Once blood 199 was collected, cervical dislocation was performed. The following tissues were collected: injection site 200 (striatum), contralateral striatum, cerebellum, inguinal lymph nodes, liver, vas deferens and epididymis 201 (V/E). Dissected tissue was collected into Eppendorf tubes and flash frozen on dry ice. Storage at -202 80°C prior to nucleic acid extraction. 203
Blood and Plasma samples 204
Immediately after collection of blood, 0.1ml of blood was diluted in 0.15ml nuclease free water 205 (Invitrogen #10977015) and 0.75ml TRIzol LS Reagent (ThermoFisher #10296010) was added. 206
Samples were immediately flash frozen on dry ice and stored at -80°C prior to nucleic acid extraction. 207
The remaining blood collected from cardiac puncture was placed in MiniCollect K2E K2EDTA 0.5ml 208 (Greiner Bio-One #450480). Manufacturer's instructions were followed to collect the resulting plasma. 209
Plasma was stored at -80°C. 210
Ultracentrifugation of Plasma Samples 211
Plasma samples were thawed on ice. Three successive centrifugation steps were performed. The pellet 212 at each step was collected and resuspended in TRIzol Reagent (ThermoFisher #15596026), while the 213 supernatant was centrifuged again. The first centrifugation step was performed at 3,000 x g for 10 214 minutes at 4°C. The second centrifugation step performed was 12,000 x g for 45 minutes at 4°C. The 215 final centrifugation step performed was 110,000 x g for 70 minutes at 4°C in a Hitachi Micro 216 Ultracentrifuge CS150NX. Samples were immediately flash frozen on dry ice and stored at -80°C prior 217 to nucleic acid extraction. 218
Homogenization of tissue samples 219
Tissue samples were transferred while still frozen into screw capped tubes containing approximately 8-220 10 1.4mm zirconium oxide beads (Bertin Technologies KT03961-1-103.BK). Samples had appropriate 221 amounts of TRIzol Reagent (ThermoFisher #15596026) added as per manufacturer's instructions. 222
Samples were homogenized in Precellys 24 (ThermoFisher) twice at 6,000rpm for 30 seconds with a 223 hold period in between. The homogenized sample was transferred into an Eppendorf tube to remove the 224 beads. The samples were then centrifuged 12,000 x g for 5 minutes at 4°C. The supernatant was 225 collected in a new Eppendorf tube. Samples were stored at -80°C prior to nucleic acid extraction. 226
Extraction of nucleic acids (RNA and DNA) 227
RNA and DNA were extracted from each sample. All samples had appropriate amounts of chloroform 228 added to the TRIzol Reagent/TRIzol LS Reagent as per manufacturer's instructions. The aqueous layer 229 that formed after centrifugation at 12,000 x g for 15 minutes at 4°C was collected and combined with 230 1.5 x volume 100% ethanol. Purification of microRNA and total RNA from this fraction was 231 performed using miRNeasy Mini/Micro Kit (Qiagen #217004/#217084) as per manufacturer's 232 instructions. On-column DNase digestion was performed using the RNase-Free DNase Set (Qiagen 233 #79254). 234
After the aqueous phase was collected for extraction of RNA, the remaining interphase and phenol 235 chloroform phase was used to extract DNA with the addition of Back Extraction Buffer (BEB -4M 236 guanidine thiocyanate, 50mM sodium citrate, 1M Tris), 0.25ml BEB per 0.5ml TRIzol. The solution 237 was shaken vigorously for 15 seconds, incubated at room temperature for 10 minutes and then 238 centrifugated at 12,000 x g for 15 minutes at 4°C. The resulting aqueous layer was collected, mixed 239
with 1 x volume of 100% ethanol, and the DNA was purified using DNeasy Blood & Tissue Kit 240 (Qiagen #69506) as per manufacturer's instructions. 241 RNA/DNA was quantified using NanoDrop Lite (ThermoFisher). 
Real-time PCR amplification with LNA-enhanced primers 249
Real-time PCR was performed using components from miRCURY LNA miRNA PCR Starter Kit. All 250 runs were performed using the QuantStudio5 Real-Time PCR System (Applied Biosystems) in "fast" 251 mode using ROX as the passive reference dye. Each reaction had a total volume of 10µl. 252
hsa-MIR-941miRCURY LNA miRNA PCR Assay 253
This was a pre-designed, validated assay to target hsa-MIR-941 (Qiagen product# 339306, catalogue# 254 YP00204574). Each 10µl reaction was made up of the following: 5µl 2 x miRCURY SYBR Green 255
Master Mix, 0.05µl ROX Reference Dye, 1.95µl PCR primer mix, 3µl of cDNA template (diluted 256 1:10). The PCR was initially heat activated at 95°C for 2 minutes, followed by 40 cycles of 257 denaturation (95°C for 10 seconds) and combined annealing/extension (60°C for 60 seconds). 258
UniSp6 miRCURY LNA miRNA PCR Assay 259
This was a pre-designed, validated assay to target UniSp6 (Qiagen product# 339306, catalogue# 260 YP00203954) which is a cDNA synthesis/PCR control. Each 10µl reaction was made up of the 261 following: 5µl 2 x miRCURY SYBR Green Master Mix, 0.05µl ROX Reference Dye, 1µl PCR primer 262 mix, 0.95µl nuclease-free water, 3µl of cDNA template (diluted 1:60). The reaction was initially heat 263 activated at 95°C for 2 minutes, followed by 40 cycles of denaturation (95°C for 10 seconds) and 264 combined annealing/extension (60°C for 60 seconds). All reactions were positive for UniSp6. 265 
Supplemental Information 359
Melting temperatures (Tm) for (*) positive calls for MIR941 on the gels (Figures 1-3) . 360 The following represent positive calls made in the main text as an asterix (*) in figures 1-3. For a 361 'positive' call, there needed to be a correct size band on the gel (products generated by LNA qPCR), a 362 graphical 'positive' via melt curve analysis and Tm values that were consistent with positive control 363 values in each run. 364 (All other Tm values were either significantly divergent from these 'positive' values or 'undetermined') 365 
